Cargando…

The role of herd immunity in control of measles.

Measles vaccine cannot give high sero-conversion rates in developing countries. The high birth rates characteristic of these countries lead to infection at a very early age, thus making it difficult to vaccinate before exposure to the disease. Nevertheless, if given early in life, the vaccine can re...

Descripción completa

Detalles Bibliográficos
Autor principal: Black, F. L.
Formato: Texto
Lenguaje:English
Publicado: Yale Journal of Biology and Medicine 1982
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2596463/
https://www.ncbi.nlm.nih.gov/pubmed/7180027
_version_ 1782161852148482048
author Black, F. L.
author_facet Black, F. L.
author_sort Black, F. L.
collection PubMed
description Measles vaccine cannot give high sero-conversion rates in developing countries. The high birth rates characteristic of these countries lead to infection at a very early age, thus making it difficult to vaccinate before exposure to the disease. Nevertheless, if given early in life, the vaccine can reduce the rate of virus circulation and thus raise the age at which children are infected. Once that is done, higher sero-conversion rates can be obtained by raising the age at vaccination. During the period when vaccine is given at an early age, the titers in responding children will be low, and this will leave children of the next generation with little protection. It is important, therefore, that if vaccine is used early the program be intensively and consistently applied to control virus circulation before the next generation is born.
format Text
id pubmed-2596463
institution National Center for Biotechnology Information
language English
publishDate 1982
publisher Yale Journal of Biology and Medicine
record_format MEDLINE/PubMed
spelling pubmed-25964632008-12-05 The role of herd immunity in control of measles. Black, F. L. Yale J Biol Med Research Article Measles vaccine cannot give high sero-conversion rates in developing countries. The high birth rates characteristic of these countries lead to infection at a very early age, thus making it difficult to vaccinate before exposure to the disease. Nevertheless, if given early in life, the vaccine can reduce the rate of virus circulation and thus raise the age at which children are infected. Once that is done, higher sero-conversion rates can be obtained by raising the age at vaccination. During the period when vaccine is given at an early age, the titers in responding children will be low, and this will leave children of the next generation with little protection. It is important, therefore, that if vaccine is used early the program be intensively and consistently applied to control virus circulation before the next generation is born. Yale Journal of Biology and Medicine 1982 /pmc/articles/PMC2596463/ /pubmed/7180027 Text en
spellingShingle Research Article
Black, F. L.
The role of herd immunity in control of measles.
title The role of herd immunity in control of measles.
title_full The role of herd immunity in control of measles.
title_fullStr The role of herd immunity in control of measles.
title_full_unstemmed The role of herd immunity in control of measles.
title_short The role of herd immunity in control of measles.
title_sort role of herd immunity in control of measles.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2596463/
https://www.ncbi.nlm.nih.gov/pubmed/7180027
work_keys_str_mv AT blackfl theroleofherdimmunityincontrolofmeasles
AT blackfl roleofherdimmunityincontrolofmeasles